*** Welcome to piglix ***

Inosine monophosphate dehydrogenase

IMP dehydrogenase
PDB 1meh EBI.jpg
Structure of IMPDH
Identifiers
EC number 1.1.1.205
CAS number 9028-93-7
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO
IMP dehydrogenase 1
Identifiers
Symbol IMPDH1
Alt. symbols RP10
Entrez 3614
HUGO 6052
OMIM 146690
RefSeq NM_000883
UniProt P20839
Other data
EC number 1.1.1.205
Locus Chr. 7 q31.3-q32
IMP dehydrogenase 2
Identifiers
Symbol IMPDH2
Alt. symbols IMPD2
Entrez 3615
HUGO 6053
OMIM 146691
RefSeq NM_000884
UniProt P12268
Other data
EC number 1.1.1.205
Locus Chr. 3 p21.2

IMP dehydrogenase EC 1.1.1.205 (Inosine-5'-monophosphate dehydrogenase) (Inosinic acid dehydrogenaseis) (IMPDH) an enzyme that converts inosine monophosphate to xanthosine monophosphate:

It catalyzes the rate-limiting reaction of de novo GTP biosynthesis.

IMP dehydrogenase is associated with cell proliferation and is a possible target for cancer chemotherapy. Mammalian and bacterial IMPDHs are tetramers of identical chains. There are two IMP dehydrogenase isozymes in humans. IMP dehydrogenase nearly always contains a long insertion that has two CBS domains within it.

The structure of this enzyme is composed of a TIM barrel domain with two CBS domains inserted within a loop.

It is inhibited by Mycophenolic acid, ribavirin, and 6TGMP (6-thioguanine monophosphate). 6TGMP inhibition prevents purine interconversion and thus the synthesis of purine nucleotides.

Humans express the following two IMP dehydrogenase isozymes:

This article incorporates text from the public domain Pfam and InterPro IPR001093


...
Wikipedia

...